Ellington Management Group’s Amgen AMGN Stock Holding History

Ellington Management Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,900	Closed	-$551K	–	569
2019 Q1	$551K	Buy	+2,900	New	+$554K	0.1%	215
2018 Q4	–	Sell	-2,100	Closed	-$435K	–	383
2018 Q3	$435K	Buy	+2,100	New	+$414K	0.12%	225
2018 Q2	–	Sell	-2,000	Closed	-$341K	–	497
2018 Q1	$341K	Buy	+2,000	New	+$367K	0.02%	540
2017 Q2	–	Sell	-2,000	Closed	-$328K	–	625
2017 Q1	$328K	Buy	+2,000	New	+$332K	0.01%	435
2016 Q4	–	Sell	-3,800	Closed	-$634K	–	536
2016 Q3	$634K	Buy	+3,800	New	+$643K	0.17%	198
2016 Q1	–	Sell	-1,300	Closed	-$211K	–	490
2015 Q4	$211K	Sell	1,300 -2,600	-67%	-$409K	0.07%	437
2015 Q3	$539K	Buy	3,900 +1,700	+77%	+$268K	0.15%	207
2015 Q2	$338K	Sell	2,200 -700	-24%	-$112K	0.08%	371
2015 Q1	$464K	Buy	+2,900	New	+$457K	0.1%	311

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ellington Management Group's AMGN Position: Q2 2019 in Review

Ellington Management Group sold out of Amgen (AMGN) in Q2 2019, closing a stake of 2,900 shares — an estimated $551K sold.

Ellington Management Group first reported a position in AMGN in Q1 2015 and held it in 9 quarters. The position peaked at $634K in Q3 2016. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Ellington Management Group reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Ellington Management Group sold 2,900 Amgen shares in Q2 2019, an estimated $551K.
Ellington Management Group first reported a position in Amgen in Q1 2015 and held it in 9 quarters.
Ellington Management Group's Amgen position peaked at $634K in Q3 2016.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.